- Home
- TNGX vs CADL Comparison
TNGX vs CADL Comparison
Compare TNGX & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- CADL
- Stock Information
- Founded
- TNGX 2014
- CADL 1999
- Country
- TNGX United States
- CADL United States
- Employees
- TNGX N/A
- CADL N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- TNGX Health Care
- CADL Health Care
- Exchange
- TNGX Nasdaq
- CADL Nasdaq
- Market Cap
- TNGX 317.4M
- CADL 306.4M
- IPO Year
- TNGX N/A
- CADL 2021
- Fundamental
- Price
- TNGX $1.77
- CADL $8.82
- Analyst Decision
- TNGX Strong Buy
- CADL Strong Buy
- Analyst Count
- TNGX 7
- CADL 4
- Target Price
- TNGX $12.33
- CADL $21.00
- AVG Volume (30 Days)
- TNGX 782.3K
- CADL 1.3M
- Earning Date
- TNGX 05-07-2025
- CADL 03-13-2025
- Dividend Yield
- TNGX N/A
- CADL N/A
- EPS Growth
- TNGX N/A
- CADL N/A
- EPS
- TNGX N/A
- CADL N/A
- Revenue
- TNGX $42,069,000.00
- CADL N/A
- Revenue This Year
- TNGX N/A
- CADL N/A
- Revenue Next Year
- TNGX N/A
- CADL N/A
- P/E Ratio
- TNGX N/A
- CADL N/A
- Revenue Growth
- TNGX 15.17
- CADL N/A
- 52 Week Low
- TNGX $1.72
- CADL $1.34
- 52 Week High
- TNGX $12.02
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- TNGX 32.71
- CADL 53.28
- Support Level
- TNGX $1.80
- CADL $7.65
- Resistance Level
- TNGX $2.04
- CADL $8.31
- Average True Range (ATR)
- TNGX 0.21
- CADL 0.67
- MACD
- TNGX 0.01
- CADL -0.02
- Stochastic Oscillator
- TNGX 7.46
- CADL 83.06
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.